Recently, dynamic tumour‐specific MHC‐II immuno‐PET imaging in animal models demonstrated that melanoma cells' tsMHC‐II expression, inducible by IFN‐γ, correlates positively with immunotherapy responsiveness.125. Here, IFNG is linked to melanoma.